Working… Menu

Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase (CONSTELLATION)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02032173
Recruitment Status : Terminated
First Posted : January 9, 2014
Last Update Posted : June 11, 2015
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Terminated
Estimated Primary Completion Date : January 2018
Estimated Study Completion Date : January 2018
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 March 10, 2016
April 7, 2016
2 April 11, 2016
May 16, 2016
3 May 20, 2016
June 28, 2016
4 July 11, 2018
January 7, 2019